Stephens Cuts Addus HomeCare (NASDAQ:ADUS) Price Target to $142.00

Addus HomeCare (NASDAQ:ADUS) had its target price trimmed by Stephens from $153.00 to $142.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

A number of other research firms have also weighed in on ADUS. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Oppenheimer increased their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. JMP Securities started coverage on Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. Finally, Macquarie reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $132.78.

Addus HomeCare Stock Down 1.0 %

NASDAQ:ADUS opened at $95.77 on Wednesday. Addus HomeCare has a 52 week low of $87.88 and a 52 week high of $136.72. The company has a fifty day simple moving average of $122.60 and a two-hundred day simple moving average of $126.08. The company has a market cap of $1.74 billion, a price-to-earnings ratio of 21.92, a price-to-earnings-growth ratio of 1.41 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. On average, analysts expect that Addus HomeCare will post 4.59 EPS for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Armis Advisers LLC purchased a new stake in shares of Addus HomeCare in the fourth quarter valued at about $295,000. Integrated Advisors Network LLC increased its position in Addus HomeCare by 8.5% in the 4th quarter. Integrated Advisors Network LLC now owns 4,261 shares of the company’s stock valued at $534,000 after acquiring an additional 333 shares during the period. Public Employees Retirement System of Ohio purchased a new stake in Addus HomeCare during the 4th quarter valued at approximately $4,985,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Addus HomeCare by 43.7% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 48,727 shares of the company’s stock worth $6,108,000 after acquiring an additional 14,812 shares during the period. Finally, Squarepoint Ops LLC purchased a new position in shares of Addus HomeCare in the 4th quarter valued at approximately $389,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.